Fig. 5.
Schematic representation of the irinotecan mixture model having 36% lower CL of SN-38 in patients with UGT1A1 hetero/homozygote versus wild-type genotype
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.